News
-
-
COMMUNIQUÉ DE PRESSE
enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
enVVeno Medical presents one-year data on VenoValve U.S. pivotal trial at VEITH Symposium supporting FDA pre-market authorization application. Study shows significant clinical benefits and safety profile -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site
MIRA Pharmaceuticals progresses towards clinical-stage status with Phase I/IIa trial announcement on Ketamir-2, a novel oral ketamine analog, for pain management. CHDR's PainCart technology leveraged -
COMMUNIQUÉ DE PRESSE
Datametrex Announces AI and Tech Purchase Order (P.O.)
Datametrex AI Limited receives high margin purchase orders with $500K revenue and $300K expenses, resulting in 40% gross profit margin. The company's successful financial performance showcases its capacity to excel in a competitive market environment -
